Barrett’s Ablation Techniques
Barrett’s esophagus replaces the normal squamous lining of the distal esophagus with columnar epithelium. Intestinal metaplasia in that lining raises the risk of dysplasia and adenocarcinoma. Ablation aims to destroy the abnormal mucosa so squamous epithelium can grow back.
Doctors first confirm the diagnosis with endoscopy and biopsy. Ablation is usually reserved for dysplasia or selected high-risk metaplasia. Visible nodules are often removed by endoscopic mucosal resection or submucosal dissection before the remaining flat lining is treated. That sequence reduces missed cancer and improves staging.
Radiofrequency ablation is the most widely studied method.
A balloon or focal catheter delivers controlled heat to the mucosa. The energy depth is limited. Several sessions may be needed. Complete eradication of intestinal metaplasia is the usual goal. Strictures can occur, especially after longer-segment treatment.
Cryotherapy freezes the mucosa with a spray or balloon system. Ice injury kills the surface cells. The method can treat irregular anatomy where a rigid electrode fits poorly. Swelling and pain may follow. Comparative data against radiofrequency ablation continue to grow.
Argon plasma coagulation uses ionized gas to coagulate the surface.
It is widely available. Depth control is less uniform than with dedicated radiofrequency devices. Residual buried glands can remain if treatment is too light. It still has a role in focal residual islands.
Photodynamic therapy was an earlier option. A photosensitizing drug plus light destroyed mucosa. Photosensitivity and stricture rates limited its use. It is now uncommon in most centers.
Success depends on more than the energy source. Acid suppression must be strong after treatment. Reflux control helps the new squamous lining survive. Surveillance biopsies continue, because buried metaplasia and recurrent dysplasia can appear later.
Complications include pain, bleeding, and narrowing. Rare perforation is possible. Patients need clear counseling about repeat sessions and lifelong follow-up. Ablation lowers cancer risk in appropriate dysplasia. It does not remove the need for monitoring.
Technique choice follows anatomy, dysplasia grade, prior resection, and local expertise. Radiofrequency ablation remains the default in many guidelines. Cryotherapy and argon plasma fill specific gaps. Combined resection and ablation treat both raised and flat disease.
Barrett’s ablation is therefore endoscopic field treatment after careful staging. Heat, cold, or plasma can clear abnormal mucosa. Durable benefit still requires reflux control and scheduled surveillance.